-
Moderna COVID vaccine highly effective five months after second dose: Study
expresspharma
December 03, 2021
Funded by Moderna, the study included 352,878 recipients of two doses of the vaccine matched to 352,878 unvaccinated individuals by age, sex, race and ethnicity.
-
UK orders extra 114 million COVID-19 vaccines to combat Omicron
PharmaTimes
December 03, 2021
Scientists and health experts have cautioned that the new variant could have the ability to bypass the effectiveness of vaccines that are currently available.
-
Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine
prnewswire
December 03, 2021
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need...
-
Sanofi to acquire Origimm Biotechnology to develop acne vaccine
EuropeanPharmaceuticalReview
December 03, 2021
Sanofi has entered into an agreement to acquire Origimm Biotechnology to add a potential first-in-class vaccine for acne to their pipeline.
-
Italy approves Pfizer and BioNTech’s Covid-19 vaccine for children
Pharmaceutical-Technology
December 03, 2021
The Italian Medicines Agency (AIFA) has approved the use of the Pfizer and BioNTech Covid-19 vaccine, Comirnaty, for children aged five to 11 years.
-
Fujifilm Irvine Scientific to Establish New Innovation & Collaboration Center in China
Pharmaceutical-Business-Review
December 02, 2021
Construction has begun in Suzhou and is planned for completion by March, 2022.
-
Lyophilisation technology improving thermal stability and reducing cycle times, says Recipharm expert
CPhIonline
December 02, 2021
Lyophilisation or freeze drying is an important means to improve thermal stability of a drug product, according to Thomas Becker, Quality Director and Qualified Person, Recipharm.
-
Pharma companies research whether vaccines need upgrade to fight Omicron variant
CPhIonline
December 02, 2021
It could take pharmaceutical companies months to tweak their COVID-19 vaccines to provide sufficient protection against the Omicron variant of the coronavirus if it poses a risk of serious illness.
-
CHMP issue positive opinion on Comirnaty® for five to 11 year olds
EuropeanPharmaceuticalReview
December 02, 2021
Pfizer and BioNTech have announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion on the administration of the companies’ COVID-19...
-
Scotland expands vaccine rollout in the face of rising Omicron cases
PharmaTimes
December 02, 2021
The Scottish government aims to expand and advance their COVID-19 booster programme, following the six cases of the Omicron variant that were reported as of Monday 29 November. This decision is based on advice from the Joint Committee on Vaccination...